Travere Therapeutics, Inc. (TVTX)
NASDAQ·Healthcare·Biotechnology
$52.17
+6.67%
Mkt Cap $4.55B
Analyst Ratings
Buy
15
Hold
1
Sell
0
Price Target (19 analysts)
$51.50
Range $49.00 – $54.00
Implied Upside
-1.3%
Consensus $51.50 vs current $52.17
NASDAQ·Healthcare·Biotechnology
$52.17
+6.67%
Mkt Cap $4.55B
Buy
15
Hold
1
Sell
0
Price Target (19 analysts)
$51.50
Range $49.00 – $54.00
-1.3%
Consensus $51.50 vs current $52.17